ID   CHIO_HUMAN              Reviewed;         468 AA.
AC   P52757; A4D1A2; B3VCF1; B3VCF2; B3VCF3; B3VCF7; B3VCG1; C9J7B0; E9PGE0;
AC   F8QPL9; Q2M203; Q75MM2;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   28-JUN-2023, entry version 212.
DE   RecName: Full=Beta-chimaerin;
DE   AltName: Full=Beta-chimerin;
DE   AltName: Full=Rho GTPase-activating protein 3;
GN   Name=CHN2; Synonyms=ARHGAP3, BCH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BETA-2).
RC   TISSUE=Cerebellum;
RX   PubMed=8175705; DOI=10.1016/s0021-9258(18)99959-x;
RA   Leung T., How B.-E., Manser E., Lim L.;
RT   "Cerebellar beta 2-chimaerin, a GTPase-activating protein for p21 ras-
RT   related rac is specifically expressed in granule cells and has a unique N-
RT   terminal SH2 domain.";
RL   J. Biol. Chem. 269:12888-12892(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BETA-2).
RC   TISSUE=Fetal brain;
RX   PubMed=7614486;
RA   Yuan S., Miller D.W., Barnett G.H., Hahn J.F., Williams B.R.G.;
RT   "Identification and characterization of human beta 2-chimaerin: association
RT   with malignant transformation in astrocytoma.";
RL   Cancer Res. 55:3456-3461(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 4; 5; 6; 7 AND 8).
RA   Barrio-Real L., Caloca M.J., Gonzalez-Sarmiento R.;
RT   "Identification of new alternative splicing isoforms of beta chimaerin.";
RL   Submitted (MAY-2008) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BETA-3).
RA   Zubeldia-Brenner L., Leskow F.C.;
RT   "beta3-chimaerin, a novel Rac-GAP.";
RL   Submitted (SEP-2009) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS BETA-2; 3 AND 4), AND
RP   VARIANT ARG-204.
RC   TISSUE=Caudate nucleus, Cerebellum, and Ileal mucosa;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D.,
RA   Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z., Lu F., Zeesman S.,
RA   Nowaczyk M.J., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F., Belloni E.,
RA   Shaffer L.G., Pober B., Morton C.C., Gusella J.F., Bruns G.A.P., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M., Gripp K.W.,
RA   Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H., Teebi A.,
RA   Minassian B.A., Kere J., Armengol L., Pujana M.A., Estivill X.,
RA   Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P., Zlotorynski E.,
RA   Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM BETA-2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS) OF 7-466 IN COMPLEX WITH
RP   PHORBOL-ESTER, AND ACTIVITY REGULATION.
RX   PubMed=15507211; DOI=10.1016/j.cell.2004.10.012;
RA   Canagarajah B., Leskow F.C., Ho J.Y., Mischak H., Saidi L.F.,
RA   Kazanietz M.G., Hurley J.H.;
RT   "Structural mechanism for lipid activation of the Rac-specific GAP, beta2-
RT   chimaerin.";
RL   Cell 119:407-418(2004).
CC   -!- FUNCTION: GTPase-activating protein for p21-rac. Insufficient
CC       expression of beta-2 chimaerin is expected to lead to higher Rac
CC       activity and could therefore play a role in the progression from low-
CC       grade to high-grade tumors.
CC   -!- ACTIVITY REGULATION: In the inactive state, the N terminus protrudes
CC       into the active site of the Rho-GAP domain, sterically blocking Rac
CC       binding. Phospholipid binding to the Phorbol-ester/DAG-type zinc-
CC       finger/C1 domain triggers the cooperative dissociation of these
CC       interactions, allowing the N-terminus to move out of the active site
CC       and thereby activating the enzyme. {ECO:0000269|PubMed:15507211}.
CC   -!- INTERACTION:
CC       P52757; Q8NFD2: ANKK1; NbExp=3; IntAct=EBI-714925, EBI-13280688;
CC       P52757; P16333: NCK1; NbExp=3; IntAct=EBI-714925, EBI-389883;
CC       P52757; O43639: NCK2; NbExp=6; IntAct=EBI-714925, EBI-713635;
CC       P52757; P63000: RAC1; NbExp=4; IntAct=EBI-714925, EBI-413628;
CC       P52757; Q96LD8: SENP8; NbExp=3; IntAct=EBI-714925, EBI-1041210;
CC       P52757; Q8N9I8: SHF; NbExp=3; IntAct=EBI-714925, EBI-14328833;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Peripheral membrane
CC       protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=9;
CC       Name=Beta-2;
CC         IsoId=P52757-1; Sequence=Displayed;
CC       Name=Beta-1;
CC         IsoId=P52757-2; Sequence=Not described;
CC       Name=3;
CC         IsoId=P52757-3; Sequence=VSP_046271, VSP_046272;
CC       Name=4; Synonyms=B1-CHNdel ex7p;
CC         IsoId=P52757-4; Sequence=VSP_047600, VSP_047601;
CC       Name=5; Synonyms=B1-CHNdel ex9;
CC         IsoId=P52757-5; Sequence=VSP_046271, VSP_046272, VSP_047602;
CC       Name=6; Synonyms=B1-CHNdel ex7p,11;
CC         IsoId=P52757-6; Sequence=VSP_047600, VSP_047601, VSP_047603;
CC       Name=7;
CC         IsoId=P52757-7; Sequence=VSP_046271, VSP_046272, VSP_047603;
CC       Name=8;
CC         IsoId=P52757-8; Sequence=VSP_053323;
CC       Name=Beta-3;
CC         IsoId=P52757-9; Sequence=VSP_053679;
CC   -!- TISSUE SPECIFICITY: Highest levels in the brain and pancreas. Also
CC       expressed in the heart, placenta, and weakly in the kidney and liver.
CC       Expression is much reduced in the malignant gliomas, compared to normal
CC       brain or low-grade astrocytomas.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L29126; AAA19191.1; -; mRNA.
DR   EMBL; U07223; AAA16836.1; -; mRNA.
DR   EMBL; U28926; AAA86528.1; -; mRNA.
DR   EMBL; EU732752; ACF04989.1; -; mRNA.
DR   EMBL; EU732753; ACF04990.1; -; mRNA.
DR   EMBL; EU732754; ACF04991.1; -; mRNA.
DR   EMBL; EU732758; ACF04995.1; -; mRNA.
DR   EMBL; EU732762; ACF04999.1; -; mRNA.
DR   EMBL; GQ924106; ADK47390.1; -; mRNA.
DR   EMBL; AK026415; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK313021; BAG35856.1; -; mRNA.
DR   EMBL; AK316030; BAH14401.1; -; mRNA.
DR   EMBL; AC004417; AAC06177.1; -; Genomic_DNA.
DR   EMBL; AC004593; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005232; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC007096; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC007255; AAS07498.1; -; Genomic_DNA.
DR   EMBL; CH236948; EAL24205.1; -; Genomic_DNA.
DR   EMBL; CH471073; EAW93919.1; -; Genomic_DNA.
DR   EMBL; BC112155; AAI12156.1; -; mRNA.
DR   CCDS; CCDS47566.1; -. [P52757-3]
DR   CCDS; CCDS5420.1; -. [P52757-1]
DR   CCDS; CCDS78219.1; -. [P52757-5]
DR   CCDS; CCDS94073.1; -. [P52757-4]
DR   PIR; A53764; A53764.
DR   RefSeq; NP_001035025.1; NM_001039936.2. [P52757-3]
DR   RefSeq; NP_001279998.1; NM_001293069.1.
DR   RefSeq; NP_001279999.1; NM_001293070.1.
DR   RefSeq; NP_001280000.1; NM_001293071.1.
DR   RefSeq; NP_001280002.1; NM_001293073.1. [P52757-4]
DR   RefSeq; NP_001280004.1; NM_001293075.1. [P52757-6]
DR   RefSeq; NP_001280005.1; NM_001293076.1. [P52757-5]
DR   RefSeq; NP_001280006.1; NM_001293077.1.
DR   RefSeq; NP_001280007.1; NM_001293078.1.
DR   RefSeq; NP_001280008.1; NM_001293079.1.
DR   RefSeq; NP_001280009.1; NM_001293080.1. [P52757-7]
DR   RefSeq; NP_004058.1; NM_004067.3. [P52757-1]
DR   PDB; 1XA6; X-ray; 3.20 A; A=7-468.
DR   PDBsum; 1XA6; -.
DR   AlphaFoldDB; P52757; -.
DR   SMR; P52757; -.
DR   BioGRID; 107548; 24.
DR   IntAct; P52757; 18.
DR   MINT; P52757; -.
DR   STRING; 9606.ENSP00000222792; -.
DR   BindingDB; P52757; -.
DR   ChEMBL; CHEMBL4504; -.
DR   iPTMnet; P52757; -.
DR   PhosphoSitePlus; P52757; -.
DR   BioMuta; CHN2; -.
DR   DMDM; 2506455; -.
DR   jPOST; P52757; -.
DR   MassIVE; P52757; -.
DR   MaxQB; P52757; -.
DR   PaxDb; P52757; -.
DR   PeptideAtlas; P52757; -.
DR   ProteomicsDB; 20301; -.
DR   ProteomicsDB; 3840; -.
DR   ProteomicsDB; 3841; -.
DR   ProteomicsDB; 3842; -.
DR   ProteomicsDB; 3843; -.
DR   ProteomicsDB; 56529; -. [P52757-1]
DR   Antibodypedia; 12544; 269 antibodies from 31 providers.
DR   DNASU; 1124; -.
DR   Ensembl; ENST00000222792.11; ENSP00000222792.7; ENSG00000106069.26. [P52757-1]
DR   Ensembl; ENST00000412711.7; ENSP00000486515.1; ENSG00000106069.26. [P52757-3]
DR   Ensembl; ENST00000421775.6; ENSP00000394284.2; ENSG00000106069.26. [P52757-5]
DR   Ensembl; ENST00000467441.6; ENSP00000516243.1; ENSG00000106069.26. [P52757-4]
DR   GeneID; 1124; -.
DR   KEGG; hsa:1124; -.
DR   MANE-Select; ENST00000222792.11; ENSP00000222792.7; NM_004067.4; NP_004058.1.
DR   UCSC; uc003szz.4; human. [P52757-1]
DR   AGR; HGNC:1944; -.
DR   CTD; 1124; -.
DR   DisGeNET; 1124; -.
DR   GeneCards; CHN2; -.
DR   HGNC; HGNC:1944; CHN2.
DR   HPA; ENSG00000106069; Tissue enhanced (brain, intestine).
DR   MIM; 602857; gene.
DR   neXtProt; NX_P52757; -.
DR   OpenTargets; ENSG00000106069; -.
DR   PharmGKB; PA26474; -.
DR   VEuPathDB; HostDB:ENSG00000106069; -.
DR   eggNOG; KOG1453; Eukaryota.
DR   GeneTree; ENSGT01030000234635; -.
DR   HOGENOM; CLU_015883_0_0_1; -.
DR   InParanoid; P52757; -.
DR   OMA; HCKTIFA; -.
DR   OrthoDB; 5395569at2759; -.
DR   PhylomeDB; P52757; -.
DR   TreeFam; TF342052; -.
DR   PathwayCommons; P52757; -.
DR   Reactome; R-HSA-9013149; RAC1 GTPase cycle.
DR   SignaLink; P52757; -.
DR   SIGNOR; P52757; -.
DR   BioGRID-ORCS; 1124; 10 hits in 1146 CRISPR screens.
DR   ChiTaRS; CHN2; human.
DR   EvolutionaryTrace; P52757; -.
DR   GeneWiki; Chimerin_2; -.
DR   GenomeRNAi; 1124; -.
DR   Pharos; P52757; Tbio.
DR   PRO; PR:P52757; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; P52757; protein.
DR   Bgee; ENSG00000106069; Expressed in cerebellum and 98 other tissues.
DR   ExpressionAtlas; P52757; baseline and differential.
DR   Genevisible; P52757; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0045202; C:synapse; IDA:MGI.
DR   GO; GO:0005096; F:GTPase activator activity; IDA:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IEA:InterPro.
DR   GO; GO:0043087; P:regulation of GTPase activity; IBA:GO_Central.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   CDD; cd20857; C1_betaCHN; 1.
DR   CDD; cd04372; RhoGAP_chimaerin; 1.
DR   CDD; cd10352; SH2_a2chimerin_b2chimerin; 1.
DR   Gene3D; 3.30.60.20; -; 1.
DR   Gene3D; 1.10.555.10; Rho GTPase activation protein; 1.
DR   Gene3D; 3.30.505.10; SH2 domain; 1.
DR   InterPro; IPR046349; C1-like_sf.
DR   InterPro; IPR035840; Chimaerin_SH2.
DR   InterPro; IPR017356; CHN1/CHN2.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR037860; RhoGAP_chimaerin.
DR   InterPro; IPR000198; RhoGAP_dom.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   PANTHER; PTHR46075:SF4; BETA-CHIMAERIN; 1.
DR   PANTHER; PTHR46075; CHIMERIN FAMILY MEMBER; 1.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF00620; RhoGAP; 1.
DR   Pfam; PF00017; SH2; 1.
DR   PIRSF; PIRSF038015; N-chimaerin; 1.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00324; RhoGAP; 1.
DR   SMART; SM00252; SH2; 1.
DR   SUPFAM; SSF57889; Cysteine-rich domain; 1.
DR   SUPFAM; SSF48350; GTPase activation domain, GAP; 1.
DR   SUPFAM; SSF55550; SH2 domain; 1.
DR   PROSITE; PS50238; RHOGAP; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; GTPase activation; Membrane;
KW   Metal-binding; Reference proteome; SH2 domain; Zinc; Zinc-finger.
FT   CHAIN           1..468
FT                   /note="Beta-chimaerin"
FT                   /id="PRO_0000056697"
FT   DOMAIN          59..127
FT                   /note="SH2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   DOMAIN          277..468
FT                   /note="Rho-GAP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00172"
FT   ZN_FING         214..264
FT                   /note="Phorbol-ester/DAG-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   REGION          1..20
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..19
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         1..56
FT                   /note="MAASSNSSLSGSSVSSDAEEYQPPIWKSYLYQLQQEAPRPKRIICPREVENR
FT                   PKYY -> MFSEELWLENEKKCAVVRKSKQGRKRQELLAVAFGVKVGVKGGFLWPPLKL
FT                   FACSQ (in isoform 3, isoform 5 and isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.3"
FT                   /id="VSP_046271"
FT   VAR_SEQ         1..36
FT                   /note="MAASSNSSLSGSSVSSDAEEYQPPIWKSYLYQLQQE -> MFSEELWLENEK
FT                   KCAVVRKSKQGRKRQELLAVAFGV (in isoform 4 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.3"
FT                   /id="VSP_047600"
FT   VAR_SEQ         1..15
FT                   /note="MAASSNSSLSGSSVS -> MTQTHRAKSASSCPNLLVPETWPHQVSASHAGR
FT                   SKQPQGGILKINEEHRRGAIQDLLASPGFTFGKRVVFDSHCLKRQHTFADGLHSSCT
FT                   (in isoform Beta-3)"
FT                   /evidence="ECO:0000303|Ref.4"
FT                   /id="VSP_053679"
FT   VAR_SEQ         37..217
FT                   /note="Missing (in isoform 4 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.3"
FT                   /id="VSP_047601"
FT   VAR_SEQ         49..192
FT                   /note="Missing (in isoform 8)"
FT                   /evidence="ECO:0000303|Ref.3"
FT                   /id="VSP_053323"
FT   VAR_SEQ         57..192
FT                   /note="Missing (in isoform 3, isoform 5 and isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.3"
FT                   /id="VSP_046272"
FT   VAR_SEQ         247..304
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|Ref.3"
FT                   /id="VSP_047602"
FT   VAR_SEQ         331..377
FT                   /note="DGEKADISANVYPDINIITGALKLYFRDLPIPVITYDTYSKFIDAAK -> E
FT                   (in isoform 6 and isoform 7)"
FT                   /evidence="ECO:0000303|Ref.3"
FT                   /id="VSP_047603"
FT   VARIANT         204
FT                   /note="H -> R (in dbSNP:rs3750103)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_022118"
FT   VARIANT         438
FT                   /note="P -> S (in dbSNP:rs34971642)"
FT                   /id="VAR_049136"
FT   CONFLICT        1..6
FT                   /note="MAASSN -> MRLL (in Ref. 1; AAA16836/AAA19191)"
FT                   /evidence="ECO:0000305"
FT   HELIX           29..36
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   STRAND          58..63
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   HELIX           66..73
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   STRAND          79..84
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   STRAND          86..88
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   STRAND          92..98
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   STRAND          101..104
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   STRAND          108..114
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   STRAND          116..118
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   HELIX           125..138
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   HELIX           141..146
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   HELIX           153..155
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   STRAND          156..161
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   TURN            229..231
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   TURN            237..240
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   STRAND          246..248
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   HELIX           255..257
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   TURN            266..269
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   HELIX           279..286
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   HELIX           292..303
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   STRAND          306..308
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   TURN            309..313
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   HELIX           318..328
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   TURN            331..334
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   STRAND          339..342
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   HELIX           346..358
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   HELIX           369..373
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   TURN            374..377
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   HELIX           381..392
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   HELIX           397..405
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   TURN            406..410
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   HELIX           411..414
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   TURN            415..419
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   HELIX           424..431
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   TURN            432..434
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   HELIX           445..448
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   HELIX           450..462
FT                   /evidence="ECO:0007829|PDB:1XA6"
FT   HELIX           464..467
FT                   /evidence="ECO:0007829|PDB:1XA6"
SQ   SEQUENCE   468 AA;  53924 MW;  63254958E0B5804C CRC64;
     MAASSNSSLS GSSVSSDAEE YQPPIWKSYL YQLQQEAPRP KRIICPREVE NRPKYYGREF
     HGIISREQAD ELLGGVEGAY ILRESQRQPG CYTLALRFGN QTLNYRLFHD GKHFVGEKRF
     ESIHDLVTDG LITLYIETKA AEYISKMTTN PIYEHIGYAT LLREKVSRRL SRSKNEPRKT
     NVTHEEHTAV EKISSLVRRA ALTHNDNHFN YEKTHNFKVH TFRGPHWCEY CANFMWGLIA
     QGVRCSDCGL NVHKQCSKHV PNDCQPDLKR IKKVYCCDLT TLVKAHNTQR PMVVDICIRE
     IEARGLKSEG LYRVSGFTEH IEDVKMAFDR DGEKADISAN VYPDINIITG ALKLYFRDLP
     IPVITYDTYS KFIDAAKISN ADERLEAVHE VLMLLPPAHY ETLRYLMIHL KKVTMNEKDN
     FMNAENLGIV FGPTLMRPPE DSTLTTLHDM RYQKLIVQIL IENEDVLF
//
